Fezakinumab

Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis[1].

Product Specifications

CAS Number

[1007106-86-6]

Product Name Alternative

ILV 094

UNSPSC

12352203

Target

Interleukin Related

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/fezakinumab.html

Purity

99.9

Solubility

10 mM in DMSO

Smiles

[Fezakinumab]

Molecular Weight

(144.84 kDa)

References & Citations

[1]Patrick M Brunner, et al. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. J Allergy Clin Immunol